PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Extract inhibited proliferation and induced apoptosis in SPC-A1 and NCI-H460 cells and in vivo xenograft models [PMID:39229537]
Tectorigenin inhibited tumor growth and decreased Ki67 levels in 5637 cell xenograft models, showing effects similar to cisplatin [PMID:41177012]
Leaf extract (component F2) alleviated hyperglycemia and insulin resistance in KK-Ay mice by inhibiting hepatic gluconeogenesis [PMID:30530047]
Iridal-type triterpenoid (compound 9) inhibited cell metastasis and induced G1 phase cell cycle arrest in 4T1 and MDA-MB-468 cells [PMID:37375271]
Tectorigenin inhibited pulsatile pituitary LH secretion in ovariectomized rats [PMID:15330494]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 27032710 (2016) — Belamcanda chinensis (L.) DC-An ethnopharmacological, phytochemical and pharmacological review. · Journal of ethnopharmacology
- 2.PMID: 26347953 (2015) — Belamcandae chinensis rhizome--a review of phytochemistry and bioactivity. · Fitoterapia
- 3.PMID: 29510567 (2018) — Phenolic Compounds from Belamcanda chinensis Seeds. · Molecules (Basel, Switzerland)
- 4.PMID: 41375398 (2025) — Traditional Uses, Phytochemistry, Pharmacology, and Toxicology of Belamcanda chinensis: A Review. · Plants (Basel, Switzerland)
- 5.PMID: 18058385 (2008) — Chemical constituents from Belamcanda chinensis. · Journal of Asian natural products research